These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 4017191)
1. Comparison of the binding of some carcinogenic and non-carcinogenic cyclopenta[a]phenanthrenes to DNA in vitro and in vivo. Russell JC; Bhatt TS; Jones JR; Coombs MM Carcinogenesis; 1985 Aug; 6(8):1223-5. PubMed ID: 4017191 [TBL] [Abstract][Full Text] [Related]
2. Repair of DNA adducts of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one in mouse tissues and its relation to tumor induction. Abbott PJ; Crew F Cancer Res; 1981 Oct; 41(10):4115-20. PubMed ID: 7285015 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the metabolism and DNA binding of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one by hamster embryo cells and the human hepatoma cell line HepG2. Bhatt TS Carcinogenesis; 1986 Jan; 7(1):143-8. PubMed ID: 3002653 [TBL] [Abstract][Full Text] [Related]
4. DNA adducts of the carcinogen, 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one, in vivo and in vitro: high pressure liquid chromatographic separation and partial characterization. Abbott PJ; Coombs MM Carcinogenesis; 1981; 2(7):629-36. PubMed ID: 7273342 [TBL] [Abstract][Full Text] [Related]
5. High skin tumour initiating activity of the metabolically derived trans-3,4-dihydro-3,4-diol of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one. Coombs MM; Bhatt TS Carcinogenesis; 1982; 3(4):449-51. PubMed ID: 7094207 [TBL] [Abstract][Full Text] [Related]
6. Carcinogenicity and mutagenicity of some alkoxy cyclopenta[a]phenanthren-17-ones; effect of obstructing the bay region. Bhatt TS; Hadfield ST; Coombs MM Carcinogenesis; 1982; 3(6):677-80. PubMed ID: 7116562 [TBL] [Abstract][Full Text] [Related]
7. Strain-specific tumorigenesis in mouse skin induced by the carcinogen, 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one, and its relation to DNA adduct formation and persistence. Abbott PJ Cancer Res; 1983 May; 43(5):2261-6. PubMed ID: 6831449 [TBL] [Abstract][Full Text] [Related]
8. A comparative examination of the in vitro metabolism of five cyclopenta[a]phenanthrenes of varying carcinogenic potential. Coombs MM; Russell JC; Jones JR; Ribeiro O Carcinogenesis; 1985 Aug; 6(8):1217-22. PubMed ID: 4017190 [TBL] [Abstract][Full Text] [Related]
9. The effect of methyl substituents on the in vitro metabolism of cyclopenta[a]phenanthren-17-ones: implications for biological activity. Hadfield ST; Abbott PJ; Coombs MM; Drake AF Carcinogenesis; 1984 Nov; 5(11):1395-9. PubMed ID: 6488461 [TBL] [Abstract][Full Text] [Related]
10. The presence of a trifluoromethyl rather than a methyl substituent in the bay-region greatly decreases the DNA-binding and tumour-initiating activity of the cyclopenta[alpha]phenanthren-17-ones. Boyd GW; Coombs MM; Baird WM Carcinogenesis; 1995 Oct; 16(10):2543-7. PubMed ID: 7586164 [TBL] [Abstract][Full Text] [Related]
11. Identification of the proximate and ultimate forms of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one. Coombs MM; Kissonerghis AM; Allen JA; Vose CW Cancer Res; 1979 Oct; 39(10):4160-5. PubMed ID: 476652 [No Abstract] [Full Text] [Related]
12. The relationship between metabolism, DNA binding, and carcinogenicity of 15,16-dihydro-11-methylcyclopenta(alpha)phenanthren-17-one in the presence of a microsomal enzyme inhibitor. Coombs MM; Bhatt TS; Vose CW Cancer Res; 1975 Feb; 35(2):305-9. PubMed ID: 234032 [TBL] [Abstract][Full Text] [Related]
13. Tumorigenicity of cyclopenta[a]phenanthrene derivatives and micronucleus induction in mouse skin. Baker RS; Bonin AM; Arlauskas A; He S; Coombs MM Carcinogenesis; 1992 Mar; 13(3):329-32. PubMed ID: 1547520 [TBL] [Abstract][Full Text] [Related]
14. Mass spectrometry of cyclopenta[alpha]phenanthrenes. Metabolites formed in vitro and in vivo from the carcinogen 15,16-dihydro-11-methyl-cyclopenta[alpha]phenanthren-17-one. Vose C; Coombs MM Biomed Mass Spectrom; 1977 Feb; 4(1):48-51. PubMed ID: 836943 [TBL] [Abstract][Full Text] [Related]
15. The biological activity and activation of 15,16-dihydro-1,11-methanocyclopenta[a]phenanthren-17-one, a carcinogen with an obstructed bay region. Hadfield ST; Bhatt TS; Coombs MM Carcinogenesis; 1984 Nov; 5(11):1485-91. PubMed ID: 6488473 [TBL] [Abstract][Full Text] [Related]
16. The influence of dihydrodiol conformation on the metabolic activation of cyclopenta[a]phenanthrenes. Boyd GW; Ioannides C; Coombs MM Toxicol Lett; 1995 Jan; 75(1-3):93-100. PubMed ID: 7863542 [TBL] [Abstract][Full Text] [Related]
17. In vivo formation and persistence of DNA adducts in mouse and rat skin exposed to (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene and (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene. Rojas M; Alexandrov K Carcinogenesis; 1986 Sep; 7(9):1553-60. PubMed ID: 3091285 [TBL] [Abstract][Full Text] [Related]
18. Species variation in the metabolism of 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one to its 3,4-dihydrodiol, the proximate carcinogen. Boyd GW; Coombs MM; Ioannides C; Lewis DF; Snelling J; Tsakalof A Carcinogenesis; 1995 Oct; 16(10):2351-5. PubMed ID: 7586134 [TBL] [Abstract][Full Text] [Related]
19. Mutagenic and carcinogenic metabolites of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one. Coombs MM; Bhatt TS; Kissonerghis AM; Vose CW Cancer Res; 1980 Mar; 40(3):882-6. PubMed ID: 7471101 [TBL] [Abstract][Full Text] [Related]
20. Benzo(a)pyrene-DNA adduct formation and removal in mouse epidermis in vivo and in vitro: relationship of DNA binding to initiation of skin carcinogenesis. Nakayama J; Yuspa SH; Poirier MC Cancer Res; 1984 Sep; 44(9):4087-95. PubMed ID: 6331664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]